Literature DB >> 3024928

Angiotensin converting enzyme in bronchoalveolar lavage in ARDS.

S Idell, F Kueppers, M Lippmann, H Rosen, M Niederman, A Fein.   

Abstract

Angiotensin converting enzyme (ACE) is present in the endothelial cells of the normal lung where it converts angiotensin I to angiotensin II and inactivates bradykinin. It has been suggested that during endothelial injury ACE is sloughed into the blood, and that if the alveolar capillary membrane is injured, also into the alveolar lining fluid. Seven patients with adult respiratory distress syndrome (ARDS), were compared to 11 normal control subjects, nine patients with sarcoidosis, and six with idiopathic pulmonary fibrosis. Total, differential cell counts and ACE determinations were performed on bronchoalveolar lavage fluid in the ARDS group. ACE was detectable in the BAL of all but one ARDS patient. It was concluded that BAL ACE is elevated in some ARDS patients, especially those with infectious causes of lung injury. Increased ACE may reflect endothelial damage or local increase in ACE production in response to sepsis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3024928     DOI: 10.1378/chest.91.1.52

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  21 in total

1.  Angiotensin-converting enzyme insertion/deletion polymorphism is associated with severe hypoxemia in pediatric ARDS.

Authors:  Pablo Cruces; Franco Díaz; Alonso Puga; Benjamín Erranz; Alejandro Donoso; Cristóbal Carvajal; Jan Wilhelm; Gabriela M Repetto
Journal:  Intensive Care Med       Date:  2011-10-18       Impact factor: 17.440

Review 2.  Emerging therapies for the prevention of acute respiratory distress syndrome.

Authors:  Carl A Ruthman; Emir Festic
Journal:  Ther Adv Respir Dis       Date:  2015-05-22       Impact factor: 4.031

3.  The role of plasminogen activator inhibitor-1 and angiotensin-converting enzyme gene polymorphisms in bronchopulmonary dysplasia.

Authors:  Deniz Anuk Ince; Fatma Belgin Atac; Servet Ozkiraz; Ugur Dilmen; Hande Gulcan; Aylin Tarcan; Namik Ozbek
Journal:  Genet Test Mol Biomarkers       Date:  2010-09-06

4.  The Role of Fibrinolytic System in Health and Disease.

Authors:  Hau C Kwaan
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

Review 5.  Cell Death in the Lung: The Apoptosis-Necroptosis Axis.

Authors:  Maor Sauler; Isabel S Bazan; Patty J Lee
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

6.  Angiotensin-converting enzyme activity in serum and bronchoalveolar lavage fluid after damage to the alveolo-capillary barrier in the human lung.

Authors:  R F De Jongh; W A De Backer; R Mohan; P G Jorens; F J van Overveld
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  The Angiotensin Converting Enzyme Insertion/Deletion polymorphism is not associated with an increased risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants.

Authors:  Krishna Yanamandra; John Loggins; R John Baier
Journal:  BMC Pediatr       Date:  2004-12-20       Impact factor: 2.125

8.  Ventilation-induced increases in EGFR ligand mRNA are not altered by intra-amniotic LPS or ureaplasma in preterm lambs.

Authors:  Noah H Hillman; Tate Gisslen; Graeme R Polglase; Suhas G Kallapur; Alan H Jobe
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

9.  Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers.

Authors:  Rangaprasad Sarangarajan; Robert Winn; Michael A Kiebish; Chas Bountra; Elder Granger; Niven R Narain
Journal:  J Racial Ethn Health Disparities       Date:  2020-09-08

Review 10.  Science review: apoptosis in acute lung injury.

Authors:  Gustavo Matute-Bello; Thomas R Martin
Journal:  Crit Care       Date:  2003-04-04       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.